Roche has unveiled a new ‘end-to-end’ pharma strategy which it believes will help deliver 20 transformative medicines over a ten year period.
Roche Aims To ‘Raise The Bar’ With New Wave Of Blockbusters
At an investor meeting in London, the Swiss company sets out plans for more disciplined decision-making to help it launch a new wave of blockbuster drugs.
